Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 14 studies | 24% ± 8% | |
endothelial cell | 9 studies | 24% ± 6% | |
glutamatergic neuron | 7 studies | 37% ± 21% | |
oligodendrocyte | 6 studies | 24% ± 6% | |
astrocyte | 5 studies | 27% ± 5% | |
neuron | 4 studies | 31% ± 8% | |
epithelial cell | 4 studies | 25% ± 8% | |
myofibroblast cell | 4 studies | 17% ± 1% | |
GABAergic neuron | 4 studies | 42% ± 14% | |
oligodendrocyte precursor cell | 4 studies | 28% ± 8% | |
adipocyte | 4 studies | 24% ± 5% | |
interneuron | 4 studies | 34% ± 20% | |
classical monocyte | 3 studies | 18% ± 3% | |
pericyte | 3 studies | 21% ± 4% | |
retina horizontal cell | 3 studies | 24% ± 8% | |
macrophage | 3 studies | 18% ± 0% | |
type I pneumocyte | 3 studies | 16% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3944.54 | 459 / 459 | 100% | 38.00 | 1118 / 1118 |
lung | 100% | 3560.62 | 578 / 578 | 100% | 25.89 | 1153 / 1155 |
brain | 100% | 4344.86 | 2641 / 2642 | 100% | 65.20 | 704 / 705 |
prostate | 100% | 2882.31 | 245 / 245 | 100% | 34.89 | 501 / 502 |
kidney | 100% | 2301.11 | 89 / 89 | 100% | 32.24 | 899 / 901 |
ovary | 100% | 3679.02 | 180 / 180 | 100% | 23.09 | 429 / 430 |
thymus | 100% | 4765.34 | 653 / 653 | 100% | 70.49 | 603 / 605 |
uterus | 100% | 4643.79 | 170 / 170 | 100% | 27.68 | 457 / 459 |
esophagus | 100% | 2939.56 | 1445 / 1445 | 99% | 18.62 | 182 / 183 |
bladder | 100% | 3520.43 | 21 / 21 | 99% | 23.16 | 501 / 504 |
intestine | 100% | 3303.03 | 966 / 966 | 99% | 19.63 | 521 / 527 |
adrenal gland | 100% | 2582.80 | 258 / 258 | 99% | 36.23 | 227 / 230 |
stomach | 99% | 2319.15 | 357 / 359 | 99% | 18.97 | 283 / 286 |
skin | 100% | 2515.13 | 1807 / 1809 | 96% | 24.50 | 453 / 472 |
pancreas | 96% | 1214.44 | 315 / 328 | 99% | 30.57 | 177 / 178 |
liver | 98% | 1498.54 | 222 / 226 | 95% | 15.57 | 384 / 406 |
adipose | 100% | 4342.08 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3950.81 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 23.32 | 29 / 29 |
muscle | 100% | 4463.93 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4461.93 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.47 | 1 / 1 |
heart | 99% | 2513.17 | 851 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 19.82 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 91% | 24.00 | 73 / 80 |
peripheral blood | 84% | 2146.67 | 783 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0072572 | Molecular function | poly-ADP-D-ribose binding |
Gene name | RNF146 |
Protein name | E3 ubiquitin-protein ligase RNF146 (EC 2.3.2.27) (Dactylidin) (Iduna) (RING finger protein 146) (RING-type E3 ubiquitin transferase RNF146) Ring finger protein 146 |
Synonyms | |
Description | FUNCTION: E3 ubiquitin-protein ligase that specifically binds poly-ADP-ribosylated (PARsylated) proteins and mediates their ubiquitination and subsequent degradation . May regulate many important biological processes, such as cell survival and DNA damage response . Acts as an activator of the Wnt signaling pathway by mediating the ubiquitination of PARsylated AXIN1 and AXIN2, 2 key components of the beta-catenin destruction complex . Acts in cooperation with tankyrase proteins (TNKS and TNKS2), which mediate PARsylation of target proteins AXIN1, AXIN2, BLZF1, CASC3, TNKS and TNKS2 . Recognizes and binds tankyrase-dependent PARsylated proteins via its WWE domain and mediates their ubiquitination, leading to their degradation . Different ubiquitin linkage types have been observed: TNKS2 undergoes ubiquitination at 'Lys-48' and 'Lys-63', while AXIN1 is only ubiquitinated at 'Lys-48' . May regulate TNKS and TNKS2 subcellular location, preventing aggregation at a centrosomal location . Neuroprotective protein . Protects the brain against N-methyl-D-aspartate (NMDA) receptor-mediated glutamate excitotoxicity and ischemia, by interfering with PAR-induced cell death, called parthanatos (By similarity). Prevents nuclear translocation of AIFM1 in a PAR-binding dependent manner (By similarity). Does not affect PARP1 activation (By similarity). Protects against cell death induced by DNA damaging agents, such as N-methyl-N-nitro-N-nitrosoguanidine (MNNG) and rescues cells from G1 arrest (By similarity). Promotes cell survival after gamma-irradiation . Facilitates DNA repair . . |
Accessions | V9GYY4 A0A0G2JLL7 ENST00000368314.6 [Q9NTX7-1] ENST00000610153.1 [Q9NTX7-1] ENST00000608991.5 [Q9NTX7-2] Q9NTX7 ENST00000356799.6 ENST00000610162.5 |